Reported Tuberculosis in the United States, 2021

Return to Main Menu

Table 54. Characteristics of Tuberculosis Cases Estimated to be Attributed to Recent Transmission and Extensive Recent Transmission: United States, 2020–2021

See Surveillance Slides #65, #66, and #67.

Characteristics of tuberculosis cases attributed to recent transmission and extensive recent transmission.
Characteristics Total cases1 Cases not attributed to recent transmission Cases attributed to recent transmission2 Cases attributed to extensive recent transmission3
No. (%) No. (%) No. (%)
Total 11,404 10,004 (87.7) 1,400 (12.3) 456 (4.0)
Origin of birth4
U.S.-born 3,020 2,270 (75.2) 750 (24.8) 269 (8.9)
Non-U.S.–born 8,344 7,700 (92.3) 644 (7.7) 186 (2.2)
Unknown or missing 40 34 (85.0) 6 (15.0) 1 (2.5)
Race and ethnicity
Hispanic or Latino 3,328 2,895 (87.0) 433 (13.0) 111 (3.3)
American Indian or Alaska Native 125 73 (58.4) 52 (41.6) 23 (18.4)
Asian 4,330 4,031 (93.1) 299 (6.9) 87 (2.0)
Black or African American 2,061 1,658 (80.4) 403 (19.6) 155 (7.5)
Native Hawaiian or Other Pacific Islander 164 106 (64.6) 58 (35.4) 28 (17.1)
White 1,233 1,100 (89.2) 133 (10.8) 43 (3.5)
Multiple race 100 87 (87.0) 13 (13.0) 6 (6.0)
Unknown or missing 63 54 (85.7) 9 (14.3) 3 (4.8)
Age group, years
0–4 100 59 (59.0) 41 (41.0) 5 (5.0)
5–14 117 90 (76.9) 27 (23.1) 8 (6.8)
15–24 1,063 897 (84.4) 166 (15.6) 35 (3.3)
25–44 3,344 2,881 (86.2) 463 (13.8) 160 (4.8)
45–64 3,494 3,039 (87.0) 455 (13.0) 165 (4.7)
≥65 3,286 3,038 (92.5) 248 (7.5) 83 (2.5)
Disease site
Pulmonary only 8,145 7,074 (86.9) 1,071 (13.1) 341 (4.2)
Extrapulmonary 1,738 1,593 (91.7) 145 (8.3) 43 (2.5)
Both 1,516 1,332 (87.9) 184 (12.1) 72 (4.7)
Unknown 5 5 (100.0) 0 (0.0) 0 (0.0)
Sputum smear
Positive 5,764 5,019 (87.1) 745 (12.9) 252 (4.4)
Negative 4,362 3,865 (88.6) 497 (11.4) 141 (3.2)
Not done 1,258 1,101 (87.5) 157 (12.5) 62 (4.9)
Unknown or missing 20 19 (95.0) 1 (5.0) 1 (5.0)
Cavitary disease5
Yes 136 115 (84.6) 21 (15.4) 8 (5.9)
No 1,043 912 (87.4) 131 (12.6) 53 (5.1)
Unknown or missing 13 10 (76.9) 3 (23.1) 1 (7.7)
Homeless within past year
Yes 501 365 (72.9) 136 (27.1) 65 (13.0)
No 10,777 9,530 (88.4) 1,247 (11.6) 384 (3.6)
Unknown or missing 126 109 (86.5) 17 (13.5) 7 (5.6)
Excess alcohol use within past year
Yes 1,033 802 (77.6) 231 (22.4) 97 (9.4)
No 10,162 9,033 (88.9) 1,129 (11.1) 344 (3.4)
Unknown or missing 209 169 (80.9) 40 (19.1) 15 (7.2)
Injecting drug use within past year
Yes 127 89 (70.1) 38 (29.9) 16 (12.6)
No 11,061 9,740 (88.1) 1,321 (11.9) 421 (3.8)
Unknown or missing 216 175 (81.0) 41 (19.0) 19 (8.8)
Noninjecting drug use within past year
Yes 807 552 (68.4) 255 (31.6) 98 (12.1)
No 10,385 9,281 (89.4) 1,104 (10.6) 337 (3.2)
Unknown or missing 212 171 (80.7) 41 (19.3) 21 (9.9)
Resident of a correctional facility at time of diagnosis
Yes 255 187 (73.3) 68 (26.7) 46 (18.0)
No 11,078 9,761 (88.1) 1,317 (11.9) 404 (3.6)
Unknown or missing 71 56 (78.9) 15 (21.1) 6 (8.5)
HIV status
Positive 470 397 (84.5) 73 (15.5) 28 (6.0)
Negative 9,753 8,548 (87.6) 1,205 (12.4) 392 (4.0)
Refused 229 201 (87.8) 28 (12.2) 8 (3.5)
Not offered 695 620 (89.2) 75 (10.8) 23 (3.3)
Unknown, missing or indeterminate 257 238 (92.6) 19 (7.4) 5 (1.9)
Multidrug-resistant TB
Yes 129 111 (86.0) 18 (14.0) 5 (3.9)
No 10,953 9,607 (87.7) 1,346 (12.3) 434 (4.0)
Unknown or missing 322 286 (88.8) 36 (11.2) 17 (5.3)

1Total number of M. tuberculosis genotyped cases that are eligible to be evaluated for recent transmission (i.e., complete data for the plausible-source case method’s algorithm).
2Number of cases attributed to recent transmission includes any given case with a plausible source case regardless of cluster size.
3Number of cases attributed to extensive recent transmission includes only cases in a plausible chain of transmission of six or more cases (five secondary and one source case).
4Persons born in the United States, certain U.S. territories, or elsewhere to at least one U.S. citizen parent are categorized as U.S.-born. All other persons are categorized as non-U.S.–born.
5Cavitary disease only assessed for persons with pulmonary TB and an abnormal x-ray.

Note: See Technical Notes.